메뉴 건너뛰기
Journal of Clinical Oncology
Volumn 23, Issue 32, 2005, Pages 8143-8145
Challenges and future directions in the prevention and management of prostate cancer
Author keywords

[No Author keywords available]
Indexed keywords

ANTINEOPLASTIC AGENT; DOCETAXEL; PROSTATE SPECIFIC ANTIGEN;
EID: 33846879219     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.10.001     Document Type: Review
Times cited : (1)
References (18)
  • 2
    • 33644675196 scopus 로고    scopus 로고
    • Role of diet in prostate cancer development and progression
    • Chan JM, Gann PH, Giovannucci EL: Role of diet in prostate cancer development and progression. J Clin Oncol 23:8152-8160, 2005
    • (2005) J Clin Oncol , vol.23 , pp. 8152-8160
    • Chan, J.M.1    Gann, P.H.2    Giovannucci, E.L.3
  • 3
    • 33644679967 scopus 로고    scopus 로고
    • Phase III prostate cancer prevention trials: Are the costs justified?
    • Thompson IM, Tangen CM, Klein EA, et al: Phase III prostate cancer prevention trials: Are the costs justified? J Clin Oncol 23:8161-8164, 2005
    • (2005) J Clin Oncol , vol.23 , pp. 8161-8164
    • Thompson, I.M.1    Tangen, C.M.2    Klein, E.A.3
  • 4
    • 32044460994 scopus 로고    scopus 로고
    • Active surveillance for prostate cancer: For whom?
    • Klotz L: Active surveillance for prostate cancer: For whom? J Clin Oncol 23:8165-8169, 2005
    • (2005) J Clin Oncol , vol.23 , pp. 8165-8169
    • Klotz, L.1
  • 5
    • 33644671617 scopus 로고    scopus 로고
    • Robotic-assisted laparoscopic prostatectomy: Do minimally invasive approaches offer significant advantages?
    • Smith JA Jr, Herrell SD: Robotic-assisted laparoscopic prostatectomy: Do minimally invasive approaches offer significant advantages? J Clin Oncol 23:8170-8175, 2005
    • (2005) J Clin Oncol , vol.23 , pp. 8170-8175
    • Smith Jr, J.A.1    Herrell, S.D.2
  • 6
    • 33644684276 scopus 로고    scopus 로고
    • Radiotherapy in the management of clinically localized prostate cancer: Evolving standards, consensus, controversies and new directions
    • Speight JL, Roach M III: Radiotherapy in the management of clinically localized prostate cancer: Evolving standards, consensus, controversies and new directions. J Clin Oncol 23:8176-8185, 2005
    • (2005) J Clin Oncol , vol.23 , pp. 8176-8185
    • Speight, J.L.1    Roach III, M.2
  • 7
    • 33644688251 scopus 로고    scopus 로고
    • High-risk localized prostate cancer: A case for early chemotherapy
    • Gleave M, Kelly WK: High-risk localized prostate cancer: A case for early chemotherapy. J Clin Oncol 23:8186-8191, 2005
    • (2005) J Clin Oncol , vol.23 , pp. 8186-8191
    • Gleave, M.1    Kelly, W.K.2
  • 8
    • 33644678812 scopus 로고    scopus 로고
    • Utility of prostate-specific antigen kinetics in addition to clinical factors in the selection of patients for salvage local therapy
    • Lee AK, D'Amico AV: Utility of prostate-specific antigen kinetics in addition to clinical factors in the selection of patients for salvage local therapy. J Clin Oncol 23:8192-8197, 2005
    • (2005) J Clin Oncol , vol.23 , pp. 8192-8197
    • Lee, A.K.1    D'Amico, A.V.2
  • 9
    • 33644672652 scopus 로고    scopus 로고
    • Role of salvage radical prostatectomy for recurrent prostate cancer after radiation therapy
    • Stephenson AJ, Eastham JA: Role of salvage radical prostatectomy for recurrent prostate cancer after radiation therapy. J Clin Oncol 23:8198-8203, 2005
    • (2005) J Clin Oncol , vol.23 , pp. 8198-8203
    • Stephenson, A.J.1    Eastham, J.A.2
  • 10
    • 33644699547 scopus 로고    scopus 로고
    • Parameters for treatment decisions for salvage radiation therapy
    • Hayes SB, Pollack A: Parameters for treatment decisions for salvage radiation therapy. J Clin Oncol 23:8204-8211, 2005
    • (2005) J Clin Oncol , vol.23 , pp. 8204-8211
    • Hayes, S.B.1    Pollack, A.2
  • 11
    • 33644684061 scopus 로고    scopus 로고
    • Early versus delayed androgen deprivation for prostate cancer: New fuel for an old debate
    • Ryan CJ, Small EJ: Early versus delayed androgen deprivation for prostate cancer: New fuel for an old debate. J Clin Oncol 23:8225-8231, 2005
    • (2005) J Clin Oncol , vol.23 , pp. 8225-8231
    • Ryan, C.J.1    Small, E.J.2
  • 12
    • 33644664272 scopus 로고    scopus 로고
    • Should intermittent androgen deprivation be used in routine clinical practice?
    • Bhandari MS, Crook J, Hussain M: Should intermittent androgen deprivation be used in routine clinical practice? J Clin Oncol 23:8212-8218, 2005
    • (2005) J Clin Oncol , vol.23 , pp. 8212-8218
    • Bhandari, M.S.1    Crook, J.2    Hussain, M.3
  • 13
    • 33644675811 scopus 로고    scopus 로고
    • Biology of progressive, castration-resistant prostate cancer: Directed therapies targeting the androgen-receptor signaling axis
    • Scher HI, Sawyers CL: Biology of progressive, castration-resistant prostate cancer: Directed therapies targeting the androgen-receptor signaling axis. J Clin Oncol 23:8253-8261, 2005
    • (2005) J Clin Oncol , vol.23 , pp. 8253-8261
    • Scher, H.I.1    Sawyers, C.L.2
  • 14
    • 33644686825 scopus 로고    scopus 로고
    • Pathogenesis and treatment of prostate cancer bone metastases: Targeting the lethal phenotype
    • Loberg RD, Logothetis CJ, Keller ET, et al: Pathogenesis and treatment of prostate cancer bone metastases: Targeting the lethal phenotype. J Clin Oncol 23:8232-8241, 2005
    • (2005) J Clin Oncol , vol.23 , pp. 8232-8241
    • Loberg, R.D.1    Logothetis, C.J.2    Keller, E.T.3
  • 15
    • 33644697100 scopus 로고    scopus 로고
    • Prostate cancer immunology: Biology, therapeutics, and challenges
    • Webster WS, Small EJ, Rini B, et al: Prostate cancer immunology: Biology, therapeutics, and challenges. J Clin Oncol 23:8262-8269, 2005
    • (2005) J Clin Oncol , vol.23 , pp. 8262-8269
    • Webster, W.S.1    Small, E.J.2    Rini, B.3
  • 16
    • 33644666787 scopus 로고    scopus 로고
    • Bisphosphonates for treatment and prevention of bone metastases
    • Michaelson MD, Smith MR: Bisphosphonates for treatment and prevention of bone metastases. J Clin Oncol 23:8219-8224, 2005
    • (2005) J Clin Oncol , vol.23 , pp. 8219-8224
    • Michaelson, M.D.1    Smith, M.R.2
  • 17
    • 33644700607 scopus 로고    scopus 로고
    • Chemotherapy for hormone-refractory prostate cancer: Now it's a question of When?
    • Ryan CJ, Eisenberger M: Chemotherapy for hormone-refractory prostate cancer: Now it's a question of "When?" J Clin Oncol 23:8242-8246, 2005
    • (2005) J Clin Oncol , vol.23 , pp. 8242-8246
    • Ryan, C.J.1    Eisenberger, M.2
  • 18
    • 33644698567 scopus 로고    scopus 로고
    • Management of advanced prostate cancer after first-line chemotherapy
    • Berthold DR, Sternberg CN, Tannock IF: Management of advanced prostate cancer after first-line chemotherapy. J Clin Oncol 23:8247-8252, 2005
    • (2005) J Clin Oncol , vol.23 , pp. 8247-8252
    • Berthold, D.R.1    Sternberg, C.N.2    Tannock, I.F.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.